Article Details
Retrieved on: 2021-01-06 16:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Interim CEO Cary Pfeffer recently told BioPharma Dive that Faze may take aim at other neurological and neurodegenerative disorders, as well as ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here